Clinical Trials in San Francisco

Showing 5961-5980 of 9,883 trials

Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

NCT00524017

RATIONALE: Monoclonal antibodies, such as cetuximab, can block abnormal cell growth in different ways. Some block the ability of abnormal cells to grow and spread. Others find abnormal cells and help kill them or carry cell-killing substances to them. PURPOSE: This randomized phase II trial is studying how well cetuximab works in treating patients with precancerous lesions of the upper aerodigestive tract.

Head and Neck CancerPrecancerous Condition

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins35 participantsStarted May 2007

San Francisco, California, United States • Chicago, Illinois, United States • Lexington, Kentucky, United States +7 more locations

TERMINATEDNA< 1 mile

ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain

NCT00981578

A study to evaluate the safety and initial effectiveness of the ExAblate 2100 Conformal Bone System in the treatment of pain resulting from metastatic bone tumors.

Bone Metastases

InSightec37 participantsStarted Sep 2009

Duarte, California, United States • San Francisco, California, United States • Stanford, California, United States +2 more locations

Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain

Find Trials by Condition in San Francisco

Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD

Radial Artery Dilation Study: The Effect of Topical Administration of Nitroglycerin and Lidocaine Versus Lidocaine Alone of the Radial Artery Diameter

Paclitaxel in Treating Patients With Ovarian Stromal Cancer

LACTIN-V Study for Recurrent Bacterial Vaginosis

TIME Study: Therapeutic Hypothermia for Infants With Mild Encephalopathy

Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain

Aging With Dignity, Health, Optimism and Community

A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma

Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

Novel Endoluminal Clinical TreAtment of Reflux

Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C

Peanut Oral Immunotherapy in Children

S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer

A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma

BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis

A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors

Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal Disease